IRIS Accounts Production v25.2.0.378 SC488374 director 1.12.23 30.11.24 30.11.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC4883742023-11-30SC4883742024-11-30SC4883742023-12-012024-11-30SC4883742022-11-30SC4883742022-12-012023-11-30SC4883742023-11-30SC488374ns15:Scotland2023-12-012024-11-30SC488374ns14:PoundSterling2023-12-012024-11-30SC488374ns10:Director12023-12-012024-11-30SC488374ns10:PrivateLimitedCompanyLtd2023-12-012024-11-30SC488374ns10:SmallEntities2023-12-012024-11-30SC488374ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-30SC488374ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-30SC488374ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-30SC488374ns10:FullAccounts2023-12-012024-11-30SC48837412023-12-012024-11-30SC488374ns10:CompanySecretary12023-12-012024-11-30SC488374ns10:RegisteredOffice2023-12-012024-11-30SC488374ns5:CurrentFinancialInstruments2024-11-30SC488374ns5:CurrentFinancialInstruments2023-11-30SC488374ns5:ShareCapital2024-11-30SC488374ns5:ShareCapital2023-11-30SC488374ns5:CapitalRedemptionReserve2024-11-30SC488374ns5:CapitalRedemptionReserve2023-11-30SC488374ns5:RetainedEarningsAccumulatedLosses2024-11-30SC488374ns5:RetainedEarningsAccumulatedLosses2023-11-30SC488374ns5:NetGoodwill2023-12-012024-11-30SC488374ns5:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-30SC488374ns5:PlantMachinery2023-12-012024-11-30SC488374ns5:NetGoodwill2023-11-30SC488374ns5:NetGoodwill2024-11-30SC488374ns5:NetGoodwill2023-11-30SC488374ns5:PlantMachinery2023-11-30SC488374ns5:PlantMachinery2024-11-30SC488374ns5:PlantMachinery2023-11-30SC488374ns5:CostValuation2023-11-30SC488374ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-30SC488374ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-30
REGISTERED NUMBER: SC488374 (Scotland)














Unaudited Financial Statements

for the Year Ended 30 November 2024

for

McDade's Pharmacy Ltd

McDade's Pharmacy Ltd (Registered number: SC488374)






Contents of the Financial Statements
for the Year Ended 30 November 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


McDade's Pharmacy Ltd

Company Information
for the Year Ended 30 November 2024







DIRECTOR: M McDade





SECRETARY: Mrs. J McDade





REGISTERED OFFICE: 88 Belville Street
Greenock
Renfrewshire
PA15 4TA





REGISTERED NUMBER: SC488374 (Scotland)





ACCOUNTANTS: Henderson & Company
73 Union Street
Greenock
Renfrewshire
PA16 8BG

McDade's Pharmacy Ltd (Registered number: SC488374)

Balance Sheet
30 November 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - 40,000
Tangible assets 5 1,333 2,870
Investments 6 145,000 145,000
146,333 187,870

CURRENT ASSETS
Stocks 25,857 28,835
Debtors 7 260,042 279,839
Prepayments and accrued income 1,171 2,276
Cash at bank and in hand 99,937 132,629
387,007 443,579
CREDITORS
Amounts falling due within one year 8 188,314 233,676
NET CURRENT ASSETS 198,693 209,903
TOTAL ASSETS LESS CURRENT
LIABILITIES

345,026

397,773

CAPITAL AND RESERVES
Called up share capital 95 95
Capital redemption reserve 5 5
Retained earnings 344,926 397,673
345,026 397,773

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

McDade's Pharmacy Ltd (Registered number: SC488374)

Balance Sheet - continued
30 November 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 August 2025 and were signed by:





M McDade - Director


McDade's Pharmacy Ltd (Registered number: SC488374)

Notes to the Financial Statements
for the Year Ended 30 November 2024

1. STATUTORY INFORMATION

McDade's Pharmacy Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost and 15% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

McDade's Pharmacy Ltd (Registered number: SC488374)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2023 - 8 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 December 2023
and 30 November 2024 400,000
AMORTISATION
At 1 December 2023 360,000
Charge for year 40,000
At 30 November 2024 400,000
NET BOOK VALUE
At 30 November 2024 -
At 30 November 2023 40,000

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 December 2023
and 30 November 2024 19,628
DEPRECIATION
At 1 December 2023 16,758
Charge for year 1,537
At 30 November 2024 18,295
NET BOOK VALUE
At 30 November 2024 1,333
At 30 November 2023 2,870

McDade's Pharmacy Ltd (Registered number: SC488374)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 December 2023
and 30 November 2024 145,000
NET BOOK VALUE
At 30 November 2024 145,000
At 30 November 2023 145,000

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 89,013 93,829
Other debtors 171,029 186,010
260,042 279,839

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts - 7,308
Trade creditors 120,837 120,358
Taxation and social security 57,232 84,017
Other creditors 10,245 21,993
188,314 233,676